Disruption of glucocorticoid receptors in the noradrenergic system leads to BDNF up-regulation and altered serotonergic transmission associated with a depressive-like phenotype in female GR(DBHCre) mice.
Recently, we have demonstrated that conditional inactivation of glucocorticoid receptors (GRs) in the noradrenergic system, may evoke depressive-like behavior in female but not male mutant mice (GR(DBHCre) mice). The aim of the current study was to dissect how selective ablation of glucocorticoid signaling in the noradrenergic system influences the previously reported depressive-like phenotype and whether it might be linked to neurotrophic alterations or secondary changes in the serotonergic system. We demonstrated that selective depletion of GRs enhances brain derived neurotrophic factor (BDNF) expression in female but not male GR(DBHCre) mice on both the mRNA and protein levels. The possible impact of the mutation on brain noradrenergic and serotonergic systems was addressed by investigating the tissue neurotransmitter levels under basal conditions and after acute restraint stress. The findings indicated a stress-provoked differential response in tissue noradrenaline content in the GR(DBHCre) female but not male mutant mice. An analogous gender-specific effect was identified in the diminished content of 5-hydroxyindoleacetic acid, the main metabolite of serotonin, in the prefrontal cortex, which suggests down-regulation of this monoamine system in female GR(DBHCre) mice. The lack of GR also resulted in an up-regulation of alpha2-adrenergic receptor (α2-AR) density in the female but not male mutants in the locus coeruleus. We have also confirmed the utility of the investigated model in pharmacological studies, which demonstrates that the depressive-like phenotype of GR(DBHCre) female mice can be reversed by antidepressant treatment with desipramine or fluoxetine, with the latter drug evoking more pronounced effects. Overall, our study validates the use of female GR(DBHCre) mice as an interesting and novel genetic tool for the investigation of the cross-connected mechanisms of depression that is not only based on behavioral phenotypes.
Department of Brain Biochemistry, Institute of Pharmacology, Polish Academy of Sciences, Kraków, Poland.
Piotr
P
Chmielarz
Department of Brain Biochemistry, Institute of Pharmacology, Polish Academy of Sciences, Kraków, Poland.
Grzegorz
G
Kreiner
Department of Pharmacokinetics and Drug Metabolism, Institute of Pharmacology, Polish Academy of Sciences, Kraków, Poland.
Marta
M
Kot
Department of Brain Biochemistry, Institute of Pharmacology, Polish Academy of Sciences, Kraków, Poland.
Agnieszka
A
Zelek-Molik
Department of Brain Biochemistry, Institute of Pharmacology, Polish Academy of Sciences, Kraków, Poland.
Marta
M
Kowalska
Department of Brain Biochemistry, Institute of Pharmacology, Polish Academy of Sciences, Kraków, Poland.
Monika
M
Bagińska
Department of Pharmacokinetics and Drug Metabolism, Institute of Pharmacology, Polish Academy of Sciences, Kraków, Poland.
Władysława Anna
WA
Daniel
Department of Brain Biochemistry, Institute of Pharmacology, Polish Academy of Sciences, Kraków, Poland. Electronic address: nfnalepa@cyf-kr.edu.pl.
Irena
I
Nalepa
D059331:Adrenergic Neurons / Q000378:metabolism*; D000818:Animals; D019208:Brain-Derived Neurotrophic Factor / Q000096:biosynthesis* / Q000235:genetics; D003863:Depression / Q000235:genetics / Q000378:metabolism* / Q000523:psychology; D005260:Female; D008297:Male; D051379:Mice; D008810:Mice, Inbred C57BL; D008822:Mice, Transgenic; D010641:Phenotype; D011965:Receptors, Glucocorticoid / Q000235:genetics / Q000378:metabolism*; D059326:Serotonergic Neurons / Q000378:metabolism*; D015854:Up-Regulation / Q000502:physiology
D019208:Brain-Derived Neurotrophic Factor; D011965:Receptors, Glucocorticoid
Antidepressant; Female; Gender; Glucocorticoid; Mouse; Noradrenergic